Literature DB >> 17351530

Parkinsonism caused by chronic usage of intravenous potassium permanganate.

Hasan Meral1, Yasar Kutukcu, Birgul Atmaca, Feriha Ozer, Kemal Hamamcioglu.   

Abstract

INTRODUCTION: Chronic overexposure to manganese (Mn) may cause neuronal degeneration. Manganese intoxication is well known to induce parkinsonism. Manganese intoxication may be associated with abnormal magnetic resonance (MR) imaging (abnormal signal hyperintensity in the globus pallidus and substantia nigra on T1-weighted images). CASES: We report an unusual presentation of manganese intoxication due to administration of a combination of acetylsalicylic acid and ephedrine HCl, potassium permanganate, and vinegar melted in tap water and administered parenterally as a psychostimulant substance in 2 cases who developed symptoms resembling parkinsonism. Neurologic examination of both cases revealed disturbances of the extrapyramidal system and a characteristic "cock walk." Tremor was present in the first case, whereas it was lacking in the second one. Cranial MRI showed bilateral symmetric T1-weighted hyperintense patterns in the globus pallidus, probably because of manganese accumulation. Different levels of response to levodopa were reported in the literature; in our cases, there was no response to levodopa.
CONCLUSION: Chronic overexposure to manganese may cause an atypical form of parkinsonism associated with increased T1 signal in the basal ganglia on magnetic resonance imaging.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351530     DOI: 10.1097/01.nrl.0000253089.20746.a8

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  15 in total

1.  X-ray fluorescence imaging of the hippocampal formation after manganese exposure.

Authors:  Gregory Robison; Taisiya Zakharova; Sherleen Fu; Wendy Jiang; Rachael Fulper; Raul Barrea; Wei Zheng; Yulia Pushkar
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

2.  Mechanisms of lead and manganese neurotoxicity.

Authors:  April P Neal; Tomas R Guilarte
Journal:  Toxicol Res (Camb)       Date:  2013-03-01       Impact factor: 3.524

Review 3.  Manganese and its role in Parkinson's disease: from transport to neuropathology.

Authors:  Michael Aschner; Keith M Erikson; Elena Herrero Hernández; Elena Herrero Hernández; Ronald Tjalkens
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

4.  Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism.

Authors:  Tomás R Guilarte; Neal C Burton; Jennifer L McGlothan; Tatyana Verina; Yun Zhou; Mohab Alexander; Luu Pham; Michael Griswold; Dean F Wong; Tore Syversen; Jay S Schneider
Journal:  J Neurochem       Date:  2008-09-20       Impact factor: 5.372

5.  Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates.

Authors:  Tomás R Guilarte; Neal C Burton; Tatyana Verina; Vinaykumar V Prabhu; Kevin G Becker; Tore Syversen; Jay S Schneider
Journal:  J Neurochem       Date:  2008-02-13       Impact factor: 5.372

Review 6.  Manganese and Parkinson's disease: a critical review and new findings.

Authors:  Tomás R Guilarte
Journal:  Environ Health Perspect       Date:  2010-04-19       Impact factor: 9.031

7.  Manganese-Induced Parkinsonism due to Ephedrone Abuse.

Authors:  Katrin Sikk; Sulev Haldre; Sten-Magnus Aquilonius; Pille Taba
Journal:  Parkinsons Dis       Date:  2011-02-17

Review 8.  Manganese-Induced Parkinsonism Is Not Idiopathic Parkinson's Disease: Environmental and Genetic Evidence.

Authors:  Tomás R Guilarte; Kalynda K Gonzales
Journal:  Toxicol Sci       Date:  2015-08       Impact factor: 4.849

9.  Boltushka: a homemade amphetamine-type stimulant and HIV risk in Odessa, Ukraine.

Authors:  Repsina Chintalova-Dallas; Patricia Case; Nataliya Kitsenko; Zita Lazzarini
Journal:  Int J Drug Policy       Date:  2008-10-30

10.  Manganese exposure induces α-synuclein aggregation in the frontal cortex of non-human primates.

Authors:  Tatyana Verina; Jay S Schneider; Tomás R Guilarte
Journal:  Toxicol Lett       Date:  2012-12-20       Impact factor: 4.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.